What we should know about the cellular and tissue response causing catheter obstruction in the treatment of hydrocephalus

Neurosurgery

Volumn 70, Issue 6, 2012, Pages 1589-1601

  Harris, Carolyn A ^a,b   McAllister, James P ^a,b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b University of Utah   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Catheter; Hydrocephalus; Obstruction; Shunt failure

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA; OPSONIN; POLYMACON; POVIDONE; SILICONE; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CATHETER OCCLUSION; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CEREBROSPINAL FLUID SHUNTING; CHEMICAL MODIFICATION; EOSINOPHIL; EPENDYMA CELL; ERYTHROCYTE; FOREIGN BODY REACTION; GIANT CELL; GLIOSIS; HUMAN; HYDROCEPHALUS; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; INTRACRANIAL PRESSURE; MATERIAL COATING; NONHUMAN; OPSONIZATION; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; SYSTEMATIC REVIEW; THERMAL INJURY; THROMBOCYTE; TISSUE ADHESION; TISSUE REACTION;

CATHETERS, INDWELLING; CEREBROSPINAL FLUID SHUNTS; EQUIPMENT FAILURE; HUMANS; HYDROCEPHALUS; POSTOPERATIVE COMPLICATIONS;

EID: 84861526047     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318244695f     Document Type: Review

References (165)

1. NINDS. Hydrocephalus Fact Sheet. 2011. Available at: http://www.ninds. nih.gov/disorders/hydrocephalus/detail-hydrocephalus.htm. Accessed October 5, 2011.
2. Enchev Y, Oi S. Historical trends of neuroendoscopic surgical techniques in the treatment of hydrocephalus. Neurosurg Rev. 2008;31(3):249-262.
3. The Hydrocephalus Association. The Stats on Hydrocephalus. 2009. Available at: http://www.hydroassoc.org/about-the-hydrocephalus-association/ hydrocephalusmedia-resources/hydrocephalus-statistics/. Accessed October 5, 2011.
4. Robinson S, Kaufman B, Park T. Outcome analysis of initial neonatal shunts: does the valve make a difference? Pediatr Neurosurg. 2002;37(6):287-294.
5. Walker M. Treatment of hydrocephalus: mere survival is not enough. Clin Neurosurg. 2005;52:279-282.
6. Walker M. Looking at hydrocephalus: where are we now, where are we going? Childs Nerv Syst. 2005;21(7):524-527.
7. Baru J, Bloom D, Muraszko K, Koop C. John Holter's shunt. J Am Coll Surg. 2001;192(1):79-85.
8. Madsen JR, Abazi GS, Fleming L, et al. Evaluation of the ShuntCheck noninvasive thermal technique for shunt flow detection in hydrocephalic patients. Neurosurgery. 2011;68(1):198-205; discussion 205.
9. McAllister JP II, Chovan P. Neonatal hydrocephalus. Mechanisms and consequences. Neurosurg Clin N Am. 1998;9(1):73-93.
10. Detwiler P, Porter R, Rekate H. Hydrocephalus-clinical features and management. In: Choux M, Di Rocco C, Hockley A, Walker M, eds. Pediatric Neurosurgery. Philadelphia, PA: Churchill Livingstone; 1999:253-271.
11. Del Bigio M. Cellular damage and prevention in childhood hydrocephalus. Brain Pathol. 2004;14(3):317-324.
12. Simon T, Hall M, Riva-Cambrin J, et al. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr. 2009;4(2):156-165.
13. Del Bigio M. Biological reactions to cerebrospinal fluid shunt devices: A review of the cellular pathology. Neurosurgery. 1998;42(2):319-325.
14. Serlo W, Fernell E, Heikkinen E, Anderson H, von Wendt L. Functions and complications of shunts in different etiologies of childhood hydrocephalus. Childs Nerv Syst. 1990;6(2):92-94.
15. Browd S, Ragel B, Gottfried O, Kestle J. Failure of cerebrospinal fluid shunts: part I: obstruction and mechanical failure. Pediatr Neurol. 2006;34(2):83-92.
16. Del Bigio M, Fedoroff S. Short-term response of brain tissue to cerebrospinal fluid shunts in vivo and in vitro. J Biomed Mater Res. 1992;26(8):979-987.
17. Sainte-Rose C, Piatt J, Renier D, et al. Mechanical complications in shunts. Pediatr Neurosurg. 1991-1992;17(1):2-9.
18. Mwachaka P, Obonyo N, Mutiso B, Ranketi S, Mwang'ombe N. Ventriculoperitoneal shunt complications: A three-year retrospective study in a Kenyan national teaching and referral hospital. Pediatr Neurosurg. 2010;46(1):1-5.
19. Jimenez A, Garcia-Verdugo J, Gonzalez C, et al. Disruption of the neurogenic niche in the subventricular zone of postnatal hydrocephalic hyh mice. J Neuropathol Exp Neurol. 2009;68(9):1006-1020.
20. Dominguez-Pinos M, Paez P, Jimenez A, et al. Ependymal denudation and alterations of the subventricular zone occur in human fetuses with a moderate communicating hydrocephalus. J Neuropathol Exp Neurol. 2005;64(7):595-604.
21. Sival D, Guerra M, den Dunnen W, et al. Neuroependymal denudation is in progress in full-term human foetal spina bifida aperta. Brain Pathol. 2011;21(2): 163-179.
22. Ferland R, Batiz L, Neal J, et al. Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Hum Mol Genet. 2009;18(3):497-516.
23. Batiz L, Paez P, Jimenez A, et al. Heterogeneous expression of hydrocephalic phenotype in the hyh mice carrying a point mutation in alpha-SNAP. Neurobiol Dis. 2006;23(1):152-168.
24. Sugar O, Bailey O. Subcutaneous reaction to silicone in ventriculoperitoneal shunts. Long-term results. J Neurosurg. 1974;41(3):367-371.
25. Bruni J, Del Bigio M. Reaction of periventricular tissue in the rat fourth ventricle to chronically placed shunt tubing implants. Neurosurgery. 1986;19(3):337-345.
26. Sekhar L, Moossy J, Guthkelch A. Malfunctioning ventriculoperitoneal shunts. Clinical and pathological features. J Neurosurg. 1982;56(3):411-416.
27. Koga H, Mukawa J, Nakata M, Sakuta O, Higa Y. Analysis of retained ventricular shunt catheters. Neurol Med Chir (Tokyo). 1992;32(11):824-828.
28. Krueger RC Jr., Wu H, Zandian M, et al. Neural progenitors populate the cerebrospinal fluid of preterm patients with hydrocephalus. J Pediatr. 2006;148 (3):337-340.
29. Bigner S, Elmore P, Dee A, Johnston W. The cytopathology of reactions to ventricular shunts. Acta Cytol. 1985;29(3):391-396.
30. Gower D, Lewis J, Kelly DJ. Sterile shunt malfunction. A scanning electron microscopic perspective. J Neurosurg. 1984;61(6):1079-1084.
31. Tung H, Raffel C, McComb JG. Ventricular cerebrospinal fluid eosinophilia in children with ventriculoperitoneal shunts. J Neurosurg. 1991;75:541-544.
32. Bleier R, Albrecht R. Supraependymal macrophages of third ventricle of hamster: morphological, functional and histochemical characterization in situ and in culture. J Comp Neurol. 1980;192(3):489-504.
33. Page R. Scanning electron microscopy of the ventricular system in normal and hydrocephalic rabbits. Preliminary report and atlas. J Neurosurg. 1975;42(6) 646-664.
34. Go KG, Stokroos I, Blaauw EH, Zuiderveen F, Molenaar I. Changes of ventricular ependyma and choroid plexus in experimental hydrocephalus, as observed by scanning electron microscopy. Acta Neuropathol. 1976;34(1):55-64.
35. Nakamura S, Koga N, Moriyasu N. Epiplexus cell (Kolmer cell) and its reaction against foreign bodies [in Japanese]. No To Shinkei. 1982;34(9):895-907.
36. Shimizu A, Koto M. Ultrastructure and movement of the ependymal and tracheal cilia in congenitally hydrocephalicWIC-Hyd rats. Childs Nerv Syst. 1992;8(1):25-32.
37. Drake JM, Kestle JR, Tuli S. CSF shunts 50 years on-past, present, and future. Childs Nerv Syst. 2000;16(10-11):800-804.
38. Snow R, Kossovsky N. Hypersensitivity reaction associated with sterile ventriculoperitoneal shunt malfunction. Surg Neurol. 1989;31(3):209-214.
39. Del Bigio MR, McAllister JP II. Pathophysiology of hydrocephalus. In: Choux M, DiRocco R, Hockley AD, Walker ML. Pediatric Neurosurgery. Vol 4. Philadelphia, PA: Churchill Livingstone; 1999:217-236.
40. Miller JM, McAllister JP II. Reduction of astrogliosis and microgliosis by cerebrospinal fluid shunting in experimental hydrocephalus. Cerebrospinal Fluid Res. 2007;4:5.
41. Deren K, Packer M, Forsyth J, et al. Reactive astrocytosis, microgliosis and inflammation in rats with neonatal hydrocephalus. Exp Neurol. 2010;226(1): 110-119.
42. Castejon O. Transmission electron microscope study of human hydrocephalic cerebral cortex. J Submicrosc Cytol Pathol. 1994;26(1):29-39.
43. Hasan M, Glees P. The fine structure of human cerebral perivascular pericytes and juxtavascular phagocytes: their possible role in hydrocephalic edema resolution. J Hirnforsch. 1990;31(2):237-249.
44. Jaeger C, Winn S, Tresco P, Aebischer P. Repair of the blood-brain barrier following implantation of polymer capsules. Brain Res. 1991;551(1-2):163-170.
45. Luttikhuizen DT, Harmsen MC, Van Luyn MJ. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng. 2006;12(7):1955-1970.
46. Mosher D. Adhesive proteins and their cellular receptors. Cardiovasc Pathol. 1993;2(3 suppl):149-155.
47. Scarff J. Treatment of hydrocephalus: An historical and critical review of methods and results. J Neurol Neurosurg Psychiatry. 1963;26:1-26.
48. Hynes R. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69(1):11-25.
49. Aderem A, Underhill D. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 1999;17:593-623.
50. Fournier E, Passirani C, Montero-Menei CN, Benoit JP. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. Biomaterials. 2003;24(19):3311-3331.
51. Morehead JM, Holt GR. Soft-tissue response to synthetic biomaterials. Otolaryngol Clin North Am. 1994;27(1):195-201.
52. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86-100.
53. Anderson JM. Inflammatory response to implants. ASAIO Trans. 1988;34(2): 101-107.
54. Biran R, Martin DC, Tresco PA. Neuronal cell loss accompanies the brain tissue response to chronically implanted silicon microelectrode arrays. Exp Neurol. 2005;195(1):115-126.
55. Kim YT, Hitchcock RW, Bridge MJ, Tresco PA. Chronic response of adult rat brain tissue to implants anchored to the skull. Biomaterials. 2004;25(12): 2229-2237.
56. Harris CA, Resau JH, Hudson EA, West RA, Moon C, McAllister JP II. Mechanical contributions to astrocyte adhesion using a novel in vitro model of catheter obstruction. Exp Neurol. 2010;222(2);204-210.
57. Lin J, Morris M, Olivero W, Boop F, Sanford RA. Computational and experimental study of proximal flow in ventricular catheters. Technical note. J Neurosurg. 2003;99(2):426-431.
58. Wang N, Miao H, Li Y, et al. Shear stress regulation of Kruppel-like factor 2 expression is flow pattern-specific. Biochem Biophys Res Commun. 2006;341(4): 1244-1251.
59. Zou R, Park E, Kelly E, Egnor M, Wagshul M, Madsen J. Intracranial pressure waves: characterization of a pulsation absorber with notch filter properties using systems analysis: laboratory investigation. J Neurosurg Pediatr. 2008;2(1):83-94.
60. Wagshul M, Eide P, Madsen J. The pulsating brain: A review of experimental and clinical studies of intracranial pulsatility. Fluids Barriers CNS. 2011;8(5):5.
61. Eide P, Sorteberg W. Changes in intracranial pulse pressure amplitudes after shunt implantation and adjustment of shunt valve opening pressure in normal pressure hydrocephalus. Acta Neurochir (Wien). 2008;150(11):1141-1147.
62. Banks W, Farr S, Morley J. Permeability of the blood-brain barrier to albumin and Insulin in the young and aged SAMP8 mouse. J Gerontol A Biol Sci Med Sci. 2000;55(12):B601-B606.
63. Castaneyra-Perdomo A, Munoz R, Gonzalez-Marrero I, et al. Protein changes in the cerebrospinal fluid of the different types of perinatal human hydrocephalus. Cerebrospinal Fluid Res. 2006;3(suppl 1):S56.
64. Foltz EL, Shurtleff DB. Five-year comparative study of hydrocephalus in children with and without operation (113 cases). J Neurosurg. 1963;20:1064-1079.
65. Brydon H, Hayward R, Harkness W, Bayston R. Physical properties of cerebrospinal fluid of relevance to shunt function. 1: the effect of protein upon CSF viscosity. Br J Neurosurg. 1995;9(5):639-644.
66. Godek M, Malkov G, Fisher E, Grainger D. Macrophage serum-based adhesion to plasma-processed surface chemistry is distinct from that exhibited by fibroblasts. Plasma Process Polym. 2006;3(6-7):485-497.
67. Polikov V, Hong J, Riechert W. Soluble factor effects on glial cell reactivity at the surface of gel-coated microwires. J Neurosci Methods. 2010;190:180-187.
68. Harris CA, Resau JH,Hudson EA, et al. Effects of surface wettability, flow and protein concentration on macrohage and astrocyte adhesion in an in vitro model of central nervous system catheter obstruction. J Biomed Mater Res A. 2011;97(4):433-440.
69. Brydon H, Keir G, Thompson E, Bayston R, Hayward R, Harkness W. Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption. J Neurol Neurosurg Psychiatry. 1998;64(5):643-647.
70. Wikkelso C, Blomstrand C. Cerebrospinal fluid proteins and cells in normalpressure hydrocephalus. J Neurol. 1982;228(3):171-180.
71. Ertel SI, Ratner BD, Kaul A, SchwayMB,Horbett TA. In vitro study of the intrinsic toxicity of synthetic surfaces to cells. J Biomed Mater Res. 1994;28(6):667-675.
72. Go KG, Ebels EJ, van Woerden H. Experiences with recurring ventricular catheter obstructions. Clin Neurol Neurosurg. 1981;83(2):47-56.
73. VandeVord PJ, Gupta N, Wilson RB, et al. Immune reactions associated with silicone-based ventriculo-peritoneal shunt malfunctions in children. Biomaterials. 2004;25(17):3853-3860.
74. Goldblum RM, Pelley RP, O'Donell AA, Pyron D, Heggers JP. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts. Lancet. 1992; 340(8818):510-513.
75. Cinalli G, Maixner W, Sainte-Rose C. Abdominal complications of peritoneal shunts. In: Pediatric Hydrocephalus. Milano, NY: Springer; 1961:326.
76. Clyde B, Albright A. Evidence for a patent fibrous tract in fractured, outgrown, or disconnected ventriculoperitoneal shunts. Pediatr Neurosurg. 1995;23(1):20-25.
77. Kalousdian S, Karlan MS, Williams MA. Silicone elastomer cerebrospinal fluid shunt systems. Council on Scientific Affairs, American Medical Association. Neurosurgery. 1998;42(4):887-892.
78. Bergsneider M, Egnor MR, Johnston M, et al. What we don't (but should) know about hydrocephalus. J Neurosurg. 2006;104(3 suppl):157-159.
79. Williams MA, McAllister JP, Walker ML, et al. Priorities for hydrocephalus research: report from a National Institutes of Health-sponsored workshop. J Neurosurg. 2007;107(5 suppl):345-357.
80. Borgbjerg BM, Gjerris F, Albeck MJ, Hauerberg J, Børgesen SE. Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types. Acta Neurochir (Wien). 1995;136(3-4):189-194.
81. Kehler U, Klohn A, Heese O, Gliemroth J. Hydrocephalus therapy: reduction of shunt occlusions using a peel-away sheath. Clin Neurol Neurosurg. 2003;105(4): 253-255.
82. Tuli S, O'Hayon B, Drake J, Clarke M, Kestle J. Change in ventricular size and effect of ventricular catheter placement in pediatric patients with shunted hydrocephalus. Neurosurgery. 1999;45(6):1329-1333.
83. Harris CA, McAllister JP II. Does drainage hole size influence adhesion on ventricular catheterš Childs Nerv Syst. 2011;27(8):122-132.
84. Albright A, Adelson P, Pollack I. Principles and Practice of Pediatric Neurosurgery. New York, NY: Thieme Medical Publishers, Inc; 2008:136.
85. Habal MB. The biologic basis for the clinical application of the silicones. A correlate to their biocompatibility. Arch Surg. 1984;119(7):843-848.
86. Ellis M, Kazina C, Del Bigio MR, McDonald P. Treatment of recurrent ventriculoperitoneal shunt failure associated with persistent cerebrospinal fluid eosinophilia and latex allergy by use of an "extracted" shunt. J Neurosurg Pediatr. 2008;1(3):237-239.
87. Chen H, Brook M, Sheardown H. Silicone elastomers for reduced protein adsorption. Biomaterials. 2004;25(12):2273-2282.
88. Peterson SL, McDonald A, Gourley PL, Sasaki DY. Poly(dimethylsiloxane) thin films as biocompatible coatings for microfluidic devices: cell culture and flow studies with glial cells. J Biomed Mater Res A. 2005;72(1):10-18.
89. Ratner B. Biomaterials science: overview and opportunities with special reference to organic and polymeric glow discharge plasma treatments. In: D'Agostino R, Favia P, Fracassi F, eds. Plasma Process Polyming of Polymers. Boston, MA: Kluwer Academic Publishers; 1996:453-464.
90. Hallab NJ, Bundy KJ, O'Connor K, Clark R, Moses RL. Cell adhesion to biomaterials: correlations between surface charge, surface roughness, adsorbed protein, and cell morphology. J Long Term Eff Med Implants. 1995;5(3):209-231.
91. Hallab NJ, Bundy KJ, O'Connor K, Moses RL, Jacobs JJ. Evaluation of metallic and polymeric biomaterial surface energy and surface roughness characteristics for directed cell adhesion. Tissue Eng. 2001;7(1);55-71.
92. van Kooten T, von Recum A. Cell adhesion to textured silicone surfaces: the influence of time of adhesion and texture on focal contact and fibronectin fibril formation. Tissue Eng. 1999;5(3):223-240.
93. von Recum AF, van Kooten TG. The influence of micro-topography on cellular response and the implications for silicone implants. J Biomater Sci Polym Ed. 1995;7(2):181-198.
94. Webb K, Hlady V, Tresco P. Relative importance of surface wettability and charged functional groups on NIH 3T3 fibroblast attachment, spreading, and cytoskeletal organization. J Biomed Mater Res. 1998;41(3):422-430.
95. Cox JD, Curry MS, Skirboll SK, Gourley PL, Sasaki DY. Surface passivation of a microfluidic device to glial cell adhesion: A comparison of hydrophobic and hydrophilic SAM coatings. Biomaterials. 2002;23(3):929-935.
96. Wong T, Lee L, Liu R, et al. Hydrogel ventriculoperitoneal shunt for the treatment of hydrocephalus in children. In: Matsumoto S, Tamaki N, eds. Hydrocephalus: Pathogenesis and Treatment. Tokyo, Japan: Springer-Verlag; 1991: 438-449.
97. Kopecek J, Jiyuan Y. Hydrogels as smart biomaterials. Polym Int. 2007;56(9): 1078-1098.
98. Montheard J, Chatzopoulos M, Chappard D. 2-Hydroxyethyl methacrylate (HEMA): chemical properties and applications in Biomedical fields. J Macromol Sci Polymer Rev. 1992;32(1):1-34.
99. Parsons J, Horwitz A, Schwartz M. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol. 2010;11(9):633-643.
100. Winer JP, Janmey PA, McCormick ME, Funaki M. Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng Part A. 2009;15(1):147-154.
101. DeFife KM, Shive MS, Hagen KM, Clapper DL, Anderson JM. Effects of photochemically immobilized polymer coatings on protein adsorption, cell adhesion, and the foreign body reaction to silicone rubber. J Biomed Mater Res. 1999;44(3):298-307.
102. Singhal R, Janzig D, Wahlstrand C, et al. inventors; Implantable medical device with lubricious material. US Patent 200700747322007. April 5, 2007.
103. Cagavi F, Akalan N, Celik H, Gur D, Guciz B. Effect of hydrophilic coating on microorganism colonization in silicone tubing. Acta Neurochir (Wien). 2004;146 (6):603-610; discussion 609-610.
104. Boelens JJ, Zaat SA, Meeldijk J, Dankert J. Subcutaneous abscess formation around catheters induced by viable and nonviable Staphylococcus epidermidis as well as by small amounts of bacterial cell wall components. J Biomed Mater Res. 2000;50(4):546-556.
105. Patel K, Tang H, Grever W, et al. Evaluation of polymer and self-assembled monolayer-coated silicone surfaces to reduce neural cell growth. Biomaterials. 2006;27(8):1519-1526.
106. Tang H. Characterization of Staphylococcus Epidermidis Adhesion and Colonization on Modified Silicone Surface under Batch and Flow Conditions. Detroit, MI: Wayne State University; 2006.
107. Zhong Y, Bellamkonda RV. Biomaterials for the central nervous system. J R Soc Interface. 2008;5(26):957-975.
108. Gombotz WR, Guanghui WH, Horbett TA, Hoffman AS. Protein adsorption to poly (ethylene oxide) surfaces. J Biomed Mater Res A. 1991;25(12):1547-1562.
109. Amiji M, Park K. Surface modification of polymeric biomaterials with poly (ethylene oxide), albumin, and heparin for reduced thrombogenicity. J Biomater Sci Polym Ed. 1993;4(3):217-234.
110. Merrill E, Salzman E. Polyethylene oxide as a biomaterial. ASAIO Trans. 1983;6: 60-64.
111. Lee J, Kopecekova P, Kopecek K, Andrade J. Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their applications as protein-resistant coatings. Biomaterials. 1990;11(7):455-464.
112. Gombotz WR, Guanghui WH, Horbett TA, Hoffman AS. Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res. 1991;25(12):1547-1562.
113. Koullick E, Hendriks M, Bertrand W, inventors; Occlusion resistant hydrocephalic shunt. US Patent 7,582,068, September 1, 2009.
114. Harris C, Resau J, Hudson E, et al. Reduction of protein adsorption and macrophage and astrocyte adhesion on ventricular catheters by polyethylene glycol and N-acetyl-L-cysteine. J Biomed Mater Res A. 2011;98(3):425-433.
115. Defife K, Hagen K, Clapper D, Andersen J. Photochemically immobilized polymer coatings: effects on protein adsorption, cell adhesion, and leukocyte activation. J Biomater Sci Polym Ed. 1999;10(10):1063-1074.
116. Chen H, Brook MA, Chen Y, Sheardown H. Surface properties of PEO-silicone composites: reducing protein adsorption. J Biomater Sci Polym Ed. 2005;16(4): 531-548.
117. Winslow BD, Tresco PA. Quantitative analysis of the tissue response to chronically implanted microwire electrodes in rat cortex. Biomaterials. 2010;31 (7):1558-1567.
118. Sun LT, Bencherif SA, Gilbert TW, Lotze MT, Washburn NR. Design principles for cytokine-neutralizing gels: cross-linking effects. Acta Biomater. 2010;6(12):4708-4715.
119. Zhou Z, Meyerhoff M. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin. Biomaterials. 2005;26(33):6506-6517.
120. Meythaler J, Fisher WS III, inventors. Method for reducing obstructive hydrocephalus. App. number 20060210548. September 21, 2006.
121. Lee IW, Vacanti JP, Taylor GA, Madsen JR. The living shunt: A tissue engineering approach in the treatment of hydrocephalus. Neurol Res. 2000;22(1):105-110.
122. Børgesen S, inventor. Shunt system with coating and flow restricting component exerting a passive and essentially constant resistance to outflow. App. number 20070112291. June 9, 2005.
123. Lee SA, Pinney JR, Khialeeva E, Bergsneider M, Judy JW. Functional evaluation of magnetic microactuators for removing biological accumulation: An in vitro study. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:947-950.
124. Lee SA, Vasquez DJ, Bergsneider M, Judy JW. Magnetic microactuators for MEMS-enabled ventricular catheters for hydrocephalus. Conf Proc IEEE Eng Med Biol Soc. 2006;1:2494-2497.
125. Bergsneider M, Lee S, Judy J, inventors. Self-clearing catheter for clinical implantation. App. number 20080281250. November 16, 2008.
126. Kulessa S, inventor. Catheter with block-overriding system. US patent 7226441. June 5, 2007.
127. Thomale UW, Hosch H, Koch A, et al. Perforation holes in ventricular catheters-is less more? Childs Nerv Syst. 2010;26(6):781-789.
128. Zhu C, Yago T, Lou J, Zarnitsyna VI, McEver RP. Mechanisms for flowenhanced cell adhesion. Ann Biomed Eng. 2008;36(4):604-621.
129. Long M, SLu S, Sun G. Kinetics of receptor-Ligand interactions in immune responses. Cell Mol Immunol. 2006;3(2):79-86.
130. Eymann R, Meier U, Kiefer M. Animal experiments to evaluate complications of foreign materials on silicone with shunt catheters: preliminary results. Acta Neurochir Suppl. 2010;106:91-93.
131. Lanosa XA, Colombo JA. Cell contact-inhibition signaling as part of woundhealing processes in brain. Neuron Glia Biol. 2008;4(1):27-34.
132. Evans MD, Taylor S, Dalton BA, Lohmann D. Polymer design for corneal epithelial tissue adhesion: pore density. J BiomedMater Res A. 2003;64(2):357-364.
133. Lintula L. How shunts are made. Paper presented at: It's About life: 10th National Conference on Hydrocephalus; June 20, 2008; Park City.
134. Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery. 1998;43(2): 294-303; discussion 303-305.
135. Tal MG, Peixoto AJ, Crowley ST, Denbow N, Eliseo D, Pollak J. Comparison of side hole versus non side hole high flow hemodialysis catheters. Hemodial Int. 2006;10(1):63-67.
136. Ginsberg HJ, Sum A, Drake JM, Cobbold RS. Ventriculoperitoneal shunt flow dependency on the number of patent holes in a ventricular catheter. Pediatr Neurosurg. 2000;33(1):7-11.
137. Kaufman B, Park T. Ventricular anatomy and shunt catheters. Pediatr Neurosurg. 1999;31(1):1-6.
138. Zumstein B, Landolt A. Untersuchung des an Ventrikelkathetern hydrozephaler Patienten haftenden Gewebes im Lichtund Electronenmikroskop. Acta Neurochir (Wien). 1974;30(3-4):287-298.
139. Haase J, Weeth R. Multiflanged ventricular Portnoy catheter for hydrocephalus shunts. Acta Neurochir (Wien). 1976;33(3-4):231-238.
140. Rouxhet L, Duhoux F, Borecky O, Legras R, Schneider Y. Adsorption of albumin, collagen, and fibronectin on the surface of poly(hydroxybutyratehydroxyvalerate) (PHB/HV) and poly(e-caprolactone) (PCL) films modified by an alkaline hydrolysis and of poly(ethylene terephtalate) (PET) track-etched membranes. J Biomater Sci Polym Ed. 1998;9(12):1279-1304.
141. Tung K, Chang Y, Chuang C. Effect of pore morphology on fluid flow through track-etched Polycarbonate membrane. Tamkang J Sci Eng. 2001;4(2):127-132.
142. Sevrain L, inventor. Anti-clogging ventricular catheter for cerebrospinal fluid drainage. US Patent 20100222732, September 2, 2010.
143. Watson D, inventor. Process for creating an in growth preventing indwelling catheter assembly. US Patent 7763142. July 27, 2010.
144. Medow J. The permeable proximal catheter project: A novel approach to preventing shunt obstruction. Paper presented at: American Association of Neurological Surgeons Annual Meeting, Pediatric Section, 2005.
145. Miller S, Pinchuk L, inventors. Porous ventricular catheter. US Patent 4767400. August 30, 1988.
146. Banks B, inventor. Ion beam sputter-etched ventricular catheter for hydrocephalus shunt. US Patent 4377169. March 22, 1983.
147. Yang B, inventor. Mesh ventricular catheter with antithrombogenic coating. App. number 20040236309. May 19, 2003.
148. Del Bigio M, Bruni J. Reaction of rabbit lateral periventricular tissue to shunt tubing implants. J Neurosurg. 1986;64(6):932-940.
149. Kossovsky N, Snow R. Clinical-pathological analysis of failed central nervous system fluid shunts. J Biomed Mater Res. 1989;23(1 suppl):73-86.
150. Schoener W. Evaluation of shunt failures by compliance analysis and inspection of shunt valves and shunt materials, using microscopic or scanning electron microscopic techniques. In: Matsumoto S, Tamaki N, eds. Hydrocephalus: Pathogenesis and Treatment. Tokyo, Japan: Springer Verlag; 1991:452-472.
151. Czernicki Z, Strzalkowski R, Walasek N, Gajkowska B. What can be found inside shunt catheters. Acta Neurochir Suppl. 2009;106(pt 3):81-85.
152. Ono H, Moriyama T, Uneoka K, Matsumura H, Fujita Y. Percutaneous revision of shunt with obstructed ventricular catheter (author's transl). No Shinkei Geka. 1976;4(4):365-370.
153. Ventureyra E, Higgins M. A New ventricular catheter for the prevention and treatment of proximal obstruction in cerebrospinal fluid shunts. Neurosurgery. 1994;34(5):924-926.
154. Kehler U, Regelsberger J, Gliemroth J, Westphal M. Outcome prediction of third ventriculostomy: A proposed hydrocephalus grading system. Minim Invasive Neurosurg. 2006;49(4):238-243.
155. Pattisapu JV, Trumble ER, Taylor KR, Howard PD, Kovach TM. Percutaneous endoscopic recanalization of the catheter: A new technique of proximal shunt revision. Neurosurgery. 1999;45(6):1361-1366; discussion 1366-1367.
156. Ginsberg H, Drake J, Peterson T, Cobbold R. Recanalization of obstructed cerebrospinal fluid ventricular catheters using ultrasonic cavitation. Neurosurgery. 2006;5(suppl 2):ONS403-ONS412.
157. Camlar M, Ersahin Y, Ozer FD, Sen F, Orman M. Can using a peel-away sheath in shunt implantation prevent ventricular catheter obstruction? Childs Nerv Syst. 2010;27(2):295-298.
158. Ames R. Ventriculo-peritoneal shunts in the management of hydrocephalus. J Neurosurg. 1967;27(6):525-529.
159. Nakamura S, Moriyasu N. Floating ventricular catheter: A new shunting device. Monogr Neural Sci. 1982;8:191-194.
160. Gower DJ, Watson D, Harper D. e-PTFE ventricular shunt catheters. Neurosurgery. 1992;31(6):1132-1135.
161. Bayston R, Milner R. Antimicrobial activity of silicone rubber used in hydrocephalus shunts, after impregnation with antimicrobial substances. J Clin Pathol. 1981;34(9):1057-1062.
162. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnatino with antimicrobials. J Neurol Neurosurg Psychiatry. 1989;52(5):605-609.
163. Medtronic I, inventor. 2006.
164. Liang X, Wang A, Cao T, et al. Effect of cast molded rifampicin/silicone on Staphylococcus epidermidis biofilm formation. J Biomed Mater Res A. 2006;76 (3):580-588.
165. Izci Y, Secer H, Akay C, Gonul E. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus. Neurol Res. 2009;31(3):234-237.